Driehaus Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Driehaus Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-220,264	Closed	-$1.28M	–	448
2024 Q4	$1.28M	Buy	+220,264	New	+$2.2M	0.01%	323
2023 Q4	–	Sell	-86,625	Closed	-$1.07M	–	435
2023 Q3	$1.07M	Hold	86,625	–	–	0.01%	326
2023 Q2	$782K	Buy	+86,625	New	+$523K	0.01%	322
2021 Q2	–	Sell	-171,762	Closed	-$5.7M	–	494
2021 Q1	$5.7M	Sell	171,762 -101,573	-37%	-$4.35M	0.08%	270
2020 Q4	$13.1M	Buy	+273,335	New	+$12.8M	0.21%	139

Other funds holding OLMA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LMC

Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Driehaus Capital Management's OLMA Position: Q1 2025 in Review

Driehaus Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 220,264 shares — an estimated $1.28M sold.

Driehaus Capital Management first reported a position in OLMA in Q4 2020 and held it in 5 quarters. The position peaked at $13.1M in Q4 2020. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

Driehaus Capital Management reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Driehaus Capital Management sold 220,264 Olema Pharmaceuticals shares in Q1 2025, an estimated $1.28M.
Driehaus Capital Management first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 5 quarters.
Driehaus Capital Management's Olema Pharmaceuticals position peaked at $13.1M in Q4 2020.
133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on Driehaus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.